lynoral
Pharmaranks rates Lynoral 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Lynoral (Ethinyl Estradiol) is a medication used to treat Breast Neoplasms, Hypogonadism, Premature Menopause, Menorrhagia.
Ethinyl Estradiol · by Organon
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Ethinyl Estradiol
- Form
- Tablet
- Strength
- Ethinyl Estradiol 0.01MG · Ethinyl Estradiol 0.05MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- breast neoplasms, hypogonadism, premature menopause
- Manufacturer
- Organon
- FDA application
- NDA005490
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Lynoral treat?
- Lynoral (Ethinyl Estradiol) may be used to treat breast neoplasms, hypogonadism, premature menopause, menorrhagia, prostatic neoplasms, primary ovarian insufficiency, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Lynoral rated?
- pharmaranks gives Lynoral a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Lynoral?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Lynoral. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Lynoral?
- Lynoral is marketed by Organon. You can see Organon's full profile, rating, and other products on pharmaranks.
- Is Lynoral a brand-name or generic drug?
- Lynoral is a brand-name product with the active ingredient Ethinyl Estradiol.
- Is Lynoral available over the counter?
- No. Lynoral is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Lynoral come in?
- Lynoral is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Lynoral FDA-registered?
- Lynoral is on record with the U.S. FDA under application number NDA005490. You can verify this on its official FDA label.
- Has Lynoral been recalled by the FDA?
- Lynoral has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Lynoral safe?
- There's no single safe-or-not verdict. pharmaranks gives Lynoral a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about ETHINYL ESTRADIOL
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 21,596 reports naming ETHINYL ESTRADIOL — the active ingredient in Lynoral, and the FDA flagged 67% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- product adhesion issue3,654 reports
- fatigue3,093 reports
- dyspnoea2,896 reports
- rash2,716 reports
- pruritus2,623 reports
- lower respiratory tract infection2,585 reports
- arthralgia2,559 reports
- joint swelling2,547 reports
Read these as a signal, not a rate. A report does not mean ETHINYL ESTRADIOL caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
tolak
Fluorouracil
azmiro
Testosterone Cypionate
elestrin
Estradiol
eligard kit
Leuprolide Acetate
exemestane
Exemestane
firmagon
Degarelix Acetate
Compare Lynoral head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
lynoral
72/100